1396PEfficacy and safety of crizotinib in previously...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1396PEfficacy and safety of crizotinib in previously treated patients (Pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y)

Moro-Sibilot, D, Ahn, M-J, Halmos, B, Kim, D-W, Riely, G J, Shaw, A T, Yang, P-C, Lanzalone, S, Polli, A, Wilner, K D, De Castro Carpeño, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy292.019
Date:
October, 2018
File:
PDF, 92 KB
2018
Conversion to is in progress
Conversion to is failed